Found: 57
Select item for more details and to access through your institution.
Role of CYP3A in haloperidol N-dealkylation and pharmacokinetics in rats.
- Published in:
- Fundamental & Clinical Pharmacology, 1999, v. 13, n. 3, p. 337, doi. 10.1111/j.1472-8206.1999.tb00353.x
- By:
- Publication type:
- Article
Influence of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Landiolol Hydrochloride, an Ultra-Short-Acting β<sub>1</sub>-Blocker.
- Published in:
- Drugs in R&D, 2005, v. 6, n. 6, p. 385, doi. 10.2165/00126839-200506060-00006
- By:
- Publication type:
- Article
The Influence of Pretreatment Periods with Diltiazem on Nifedipine Kinetics.
- Published in:
- 1993
- By:
- Publication type:
- Other
Pharmacokinetics of Beta-Methyldigoxin in Subjects with Normal and Impaired Renal Function.
- Published in:
- 1993
- By:
- Publication type:
- Other
The Influence of Diltiazem Versus Cimetidine on Propranolol Metabolism.
- Published in:
- Journal of Clinical Pharmacology, 1992, v. 32, n. 12, p. 1099, doi. 10.1177/009127009203201207
- By:
- Publication type:
- Article
The Effect of Diltiazem on Hepatic Drug Oxidation Assessed by Antipyrine and Trimethadione.
- Published in:
- 1991
- By:
- Publication type:
- Other
Pathological gambling associated with cabergoline in a case of recurrent depression.
- Published in:
- Drug Discoveries & Therapeutics, 2009, v. 3, n. 4, p. 190
- By:
- Publication type:
- Article
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of P-glycoprotein in risperidone disposition
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 78, n. 1, p. 43, doi. 10.1016/j.clpt.2005.03.009
- By:
- Publication type:
- Article
Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 17, doi. 10.1016/j.clpt.2004.08.026
- By:
- Publication type:
- Article
CYP3A activity in European American and Japanese men using midazolam as an in vivo probe<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 5, p. 333, doi. 10.1067/mcp.2001.115447
- By:
- Publication type:
- Article
Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 570, doi. 10.1016/S0009-9236(99)70077-9
- By:
- Publication type:
- Article
Interethnic difference in omeprazole's inhibition of diazepam metabolism<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1995, v. 58, n. 1, p. 62, doi. 10.1016/0009-9236(95)90073-X
- By:
- Publication type:
- Article
The effects of age and gender on the stereoselective pharmacokinetics of verapamil.
- Published in:
- Clinical Pharmacology & Therapeutics, 1993, v. 54, n. 3, p. 278, doi. 10.1038/clpt.1993.148
- By:
- Publication type:
- Article
Pharmacokinetics of fexofenadine enantiomers in healthy subjects.
- Published in:
- Chirality, 2007, v. 19, n. 3, p. 223
- By:
- Publication type:
- Article
Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 535, doi. 10.1111/j.1365-2125.2009.03396.x
- By:
- Publication type:
- Article
The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, n. 5, p. 693, doi. 10.1111/j.1365-2125.2008.03116.x
- By:
- Publication type:
- Article
Limited frequency of the CYP2C19* 17 allele and its minor role in a Japanese population.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, n. 3, p. 437, doi. 10.1111/j.1365-2125.2007.03057.x
- By:
- Publication type:
- Article
CYP2D6 genetic variation in Ugandans.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Weekly Paclitaxel and Nedaplatin With Concurrent Radiotherapy for Locally Advanced Non-small-cell Lung Cancer: a Phase I/II Study.
- Published in:
- Japanese Journal of Clinical Oncology, 2004, v. 34, n. 11, p. 647, doi. 10.1093/jjco/hyh119
- By:
- Publication type:
- Article
The ( R)-omeprazole hydroxylation index reflects CYP2C19 activity in healthy Japanese volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 7, p. 1423, doi. 10.1007/s00228-013-1480-1
- By:
- Publication type:
- Article
Cytochrome P450 2C19 genetic polymorphisms in Ugandans.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 6, p. 583, doi. 10.1007/s00228-008-0461-2
- By:
- Publication type:
- Article
Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 5, p. 503, doi. 10.1007/s00228-007-0455-5
- By:
- Publication type:
- Article
Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration.
- Published in:
- European Journal of Clinical Pharmacology, 2007, v. 63, n. 11, p. 1031, doi. 10.1007/s00228-007-0331-3
- By:
- Publication type:
- Article
Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations.
- Published in:
- European Journal of Clinical Pharmacology, 2007, v. 63, n. 2, p. 143, doi. 10.1007/s00228-006-0251-7
- By:
- Publication type:
- Article
Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 10, p. 855, doi. 10.1007/s00228-006-0184-1
- By:
- Publication type:
- Article
Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 8, p. 597, doi. 10.1007/s00228-006-0152-9
- By:
- Publication type:
- Article
Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 5, p. 575, doi. 10.1007/s00280-006-0298-2
- By:
- Publication type:
- Article
Chemosensitivity Determinants of Irinotecan Hydrochloride in Hepatocellular Carcinoma Cell Lines.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2008, v. 102, n. 4, p. 399, doi. 10.1111/j.1742-7843.2007.00199.x
- By:
- Publication type:
- Article
Fexofenadine does Not Affect Omeprazole Pharmacokinetics: Both are putative P-Glycoprotein Substrates.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2004, v. 94, n. 5, p. 252, doi. 10.1111/j.1742-7843.2004.pto940509.x
- By:
- Publication type:
- Article
Effects of single and multiple doses of itraconazole on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 62, n. 3, p. 372, doi. 10.1111/j.1365-2125.2006.02689.x
- By:
- Publication type:
- Article
Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 5, p. 538, doi. 10.1111/j.1365-2125.2006.02613.x
- By:
- Publication type:
- Article
Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 309, doi. 10.1111/j.1365-2125.2005.02556.x
- By:
- Publication type:
- Article
Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 315, doi. 10.1111/j.1365-2125.2005.02566.x
- By:
- Publication type:
- Article
Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 60, n. 2, p. 172, doi. 10.1111/j.1365-2125.2005.02380.x
- By:
- Publication type:
- Article
Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 60, n. 1, p. 61, doi. 10.1111/j.1365-2125.2005.02381.x
- By:
- Publication type:
- Article
Effects of clarithromycin on lansoprazole pharmacokinetics betweenCYP2C19genotypes.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 302, doi. 10.1111/j.1365-2125.2004.02329.x
- By:
- Publication type:
- Article
Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes.
- Published in:
- British Journal of Clinical Pharmacology, 2004, v. 57, n. 5, p. 569, doi. 10.1111/j.1365-2125.2003.02061.x
- By:
- Publication type:
- Article
Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes.
- Published in:
- British Journal of Clinical Pharmacology, 2004, v. 57, n. 4, p. 487, doi. 10.1111/j.1365-2125.2003.02047.x
- By:
- Publication type:
- Article
Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepam.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 4, p. 382, doi. 10.1046/j.1365-2125.2003.01775.x
- By:
- Publication type:
- Article
Ticlopidine decreases the in vivo activity of CYP2C19 as measured by omeprazole metabolism.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 4, p. 454, doi. 10.1046/j.1365-2125.1999.00914.x
- By:
- Publication type:
- Article
The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Lack of Significant Effect of Grapefruit Juice on the Pharmacokinetics of Lansoprazole and Its Metabolites in Subjects With Different CYP2C19 Genotypes.
- Published in:
- Journal of Clinical Pharmacology, 2005, v. 45, n. 6, p. 690, doi. 10.1177/0091270005275430
- By:
- Publication type:
- Article
Effects of Fluvoxamine on Lansoprazole Pharmacokinetics in Relation to CYP2C19 Genotypes.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 11, p. 1223, doi. 10.1177/0091270004269015
- By:
- Publication type:
- Article
The Effects of Ginkgo Biloba Extracts on the Pharmacokinetics and Pharmacodynamics of Donepezil.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 5, p. 538
- By:
- Publication type:
- Article
Effects of Cyp2D6 Genotypes on Plasma Concentrations of Risperidone and Enantiomers of 9-Hydroxyrisperidone in Japanese Patients with Schizophrenia.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 2, p. 122, doi. 10.1177/0091270002239819
- By:
- Publication type:
- Article
Effect of Dietary Fat Content in Meals on Pharmacokinetics of Quazepam.
- Published in:
- Journal of Clinical Pharmacology, 2002, v. 42, n. 12, p. 1335, doi. 10.1177/0091270002042012004
- By:
- Publication type:
- Article
Carbamazepine Decreases Antihypertensive Effect of Nilvadipine.
- Published in:
- Journal of Clinical Pharmacology, 2002, v. 42, n. 1, p. 100, doi. 10.1177/0091270002042001012
- By:
- Publication type:
- Article
Higher Incidence of Elevated Body Temperature or Increased C-Reactive Protein Level in Asthmatic Children Showing Transient Reduction of Theophylline Metabolism.
- Published in:
- Journal of Clinical Pharmacology, 2000, v. 40, n. 3, p. 284, doi. 10.1177/009127000004000308
- By:
- Publication type:
- Article
Effects of Diltiazem and Cimetidine on Theophylline Oxidative Metabolism.
- Published in:
- 1993
- By:
- Publication type:
- Other